Cargando…
GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma
The aim of dendritic cell (DC) vaccination in cancer is to induce tumor-specific effector T cells that may reduce and control tumor mass. Immunostimulants that could drive a desired immune response are necessary to be found in order to generate a long lasting tumor immune response. GK-1 peptide, der...
Autores principales: | Piñón-Zárate, Gabriela, Herrera-Enríquez, Miguel Ángel, Hernández-Téllez, Beatriz, Jarquín-Yáñez, Katia, Castell-Rodríguez, Andrés Eliú |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230216/ https://www.ncbi.nlm.nih.gov/pubmed/25759825 http://dx.doi.org/10.1155/2014/158980 |
Ejemplares similares
-
Corrigendum to “GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma”
por: Piñón-Zárate, Gabriela, et al.
Publicado: (2015) -
Gelatin/Hyaluronic Acid Scaffold Coupled to CpG and MAGE-A5 as a Treatment against Murine Melanoma
por: Piñón-Zárate, Gabriela, et al.
Publicado: (2022) -
Immunomodulatory Properties of Masticadienonic Acid and 3α-Hydroxy Masticadienoic Acid in Dendritic Cells
por: Piñón-Zárate, Gabriela, et al.
Publicado: (2022) -
Cellulose-Chitosan-Nanohydroxyapatite Hybrid Composites by One-Pot Synthesis for Biomedical Applications
por: Jarquin-Yáñez, Katia, et al.
Publicado: (2021) -
Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model
por: Castillo-Montiel, E., et al.
Publicado: (2015)